The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Classification of HER2 status across multiple cancers using epigenomic profiles from a novel liquid biopsy assay.
 
Anthony D'Ippolito
Employment - Kymera; Precede Bio; Syros Pharmaceuticals
Stock and Other Ownership Interests - Precede Bio; Syros Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Precede Bio; Syros Pharmaceuticals
 
Jonathan Beagan
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
Travel, Accommodations, Expenses - Precede Bio
 
Melissa E. Hughes
No Relationships to Disclose
 
Matthew Strickland
No Relationships to Disclose
 
Martin Samuel Taylor
Stock and Other Ownership Interests - ROME Therapeutics
Consulting or Advisory Role - ROME Therapeutics; Tessera Therapeutics
Patents, Royalties, Other Intellectual Property - Millipore-Sigma anti-LINE1 antibodies); Ultrasensitive Assays for Detection of ORF1p in Biofluids
 
Corrie Painter
Employment - Precede Bio
Stock and Other Ownership Interests - Precede Bio
Consulting or Advisory Role - One Health Company; Precede Bio
 
Kalie Smith
No Relationships to Disclose
 
Aditya Pandey
No Relationships to Disclose
 
Ilexa A Schechter
No Relationships to Disclose
 
Mosammat F Afreen
No Relationships to Disclose
 
Jayne Stommel
No Relationships to Disclose
 
Aparna Gorthi
Employment - AstraZeneca; Precede Bio
Stock and Other Ownership Interests - Precede Bio
 
Nancy U. Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Eisai; Johnson & Johnson/Janssen; Menarini; Olema Pharmaceuticals; Pfizer; Seagen
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
Travel, Accommodations, Expenses - Olema Pharmaceuticals
 
Matthew Freedman
Stock and Other Ownership Interests - Precede Bio
Consulting or Advisory Role - Precede Bio
Patents, Royalties, Other Intellectual Property - A pending patent has been filed for detecting neuroendocrine prostate cancer using DNA methylation
 
Heather Anne Parsons
Honoraria - Guardant Health
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo/UCB Japan; Natera; SAGA Diagnostics; Sermonix Pharmaceuticals
Research Funding - GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - NeoGenomics Laboratories; SAGA Diagnostics
 
Samuel J. Klempner
Stock and Other Ownership Interests - Nuvalent, Inc.; TP Therapeutics
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Exact Sciences; I-Mab; Merck; Mersana; Novartis; Sanofi/Aventis; SERVIER
Research Funding - Arcus Biosciences (Inst); BeiGene (Inst); Leap Therapeutics (Inst); Silverback Therapeutics (Inst)
Other Relationship - Clinical Care Options; NCCN; Research to Practice
 
Gordon B. Mills
Stock and Other Ownership Interests - Bluedot; Catena; ImmunoMET; Nuvectis Pharma; SignalChem; Tarveda Therapeutics; Turbine
Honoraria - Amphista Therapeutics; Astex Pharmaceuticals; AstraZeneca; BlueDot; Chrysalis biotherapeutics; Ellipses Pharma; GlaxoSmithKline; ImmunoMET; Infinity Pharmaceuticals; Ionis Pharmaceuticals; Leapfrog Bio; Lilly; MedaCorp; NanoString Technologies; Nuvectis Pharma; PDX Pharmacy; Qureator; Roche; SignalChem; Symphogen; Tarveda Therapeutics; Turbine; Zentalis
Consulting or Advisory Role - Amphista Therapeutics; Astex Pharmaceuticals; AstraZeneca; BlueDot; Chrysalis biotherapeutics; Ellipses Pharma; GlaxoSmithKline; ImmunoMET; Infinity Pharmaceuticals; Ionis Pharmaceuticals; Leapfrog Bio; Lilly; MedaCorp; NanoString Technologies; Nuvectis Pharma; PDX Pharmacy; Qureator; Roche; SignalChem; Symphogen; Tarveda Therapeutics; Turbine; Zentalis
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; Genentech; GlaxoSmithKline; ImmunoMET; Komipharm; Lilly; NanoString Technologies; Ovarian Cancer Research Foundation; Prospect Creek Foundation
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen
 
Sara M. Tolaney
Consulting or Advisory Role - AADi; ARC Therapeutics; Artios Biopharmaceuticals; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; CytomX Therapeutics; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Infinity Pharmaceuticals; Jazz Pharmaceuticals; Lilly; Menarini Group; Merck; Natera; Novartis; OncXerna Therapeutics; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Systimmune; Tango Therapeutics; Umoja Biopharma; Zentalis; Zetagen; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Sanofi
 
Matthew Eaton
Employment - Precede Bio; Syros Pharmaceuticals; Vor Biopharma (I)
Stock and Other Ownership Interests - Precede Bio; Syros Pharmaceuticals; Tome Biosciences (I); Vor Biosciences
 
J. Carl Barrett
Employment - AstraZeneca; Precede Bio
Leadership - Corista; SAGA Diagnostics
Stock and Other Ownership Interests - AstraZeneca; Corista; Precede Bio; SAGA Diagnostics
Consulting or Advisory Role - Bio-AI Health; ExAI